Skip to main content
. Author manuscript; available in PMC: 2010 Mar 15.
Published in final edited form as: Arthritis Rheum. 2009 Mar 15;61(3):370–377. doi: 10.1002/art.24356

Table 1. Members of SLE Quality Indicators Project Advisory Panel and RAND/UCLA Appropriateness Method Expert Panel.

SLE QI Project Advisory Panel Primary Practice Setting
Moderator
 David Wofsy, MD University of California, San Francisco
Panelists
 Eliza Chakravarty, MD, MSc Stanford University
 Maria Dall'Era, MD University of California, San Francisco
 James Davis, MD* Sutter Health, San Francisco
 John C. Davis, Jr., MD, MPH University of California, San Francisco
 Kenneth Kalunian, MD University of California, San Diego
 Nina D. Schwartz, MD Kaiser Permanente, South San Francisco
 Daniel J. Wallace, MD David Geffen School of Medicine at UCLA
 Michael M. Ward, MD NIH/NIAMS
SLE QI Project RAND/UCLA Appropriateness Method Panel

Moderator
 Catherine MacLean, MD, PhD University of California, Los Angeles
Panelists
 Rashmi B. Dixit, MD, PhD Walnut Creek, California
 Richard Furie, MD North Shore-Long Island Jewish Health System
 Jennifer Grossman, MD David Geffen School of Medicine at UCLA
 Lester Miller, MD Santa Cruz, California
 Rosalind Ramsey-Goldman, MD, DrPh Feinberg School of Medicine, Northwestern University
 Brad Rovin, MD* Ohio State University
 Kenneth Saag, MD University of Alabama at Birmingham
 Jorge Sanchez-Guerrero, MD, MS National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico
 David Wofsy, MD University of California, San Francisco
*

James Davis practices Internal Medicine and Rheumatology. Brad Rovin is a nephrologist. All others primarily practice Rheumatology.

John C. Davis, Jr. is currently employed at Genentech, Inc. He was employed at the University of California, San Francisco when asked to sit on the panel.

Catherine MacLean is also Director of Programs in Clinical Excellence at Wellpoint, Inc.